Anhui Ribobay Pharmaceutical Co., Ltd. (referred to as Ribobay ), established in August 2021, is a wholly-owned subsidiary of General Biol. The company is located in Quanjiao industry Zone in Chuzhou, part of the Nanjing metropolitan area. Ribobay Pharmaceutical focuses on the field of medicinal oligonucleotides CXO, which is one of the important layouts for General Biol's CXO business expansion.